Pharmacokinetic alterations after severe head injury. Clinical relevance.
about
Anti-epileptogenic clinical trial designs in epilepsy: issues and optionsPrevalence and characteristics of adverse drug reactions in neurosurgical intensive care patients.Controversies in blood-level monitoring: reexamining its role in the treatment of epilepsy.Steady-state serum concentrations of progesterone following continuous intravenous infusion in patients with acute moderate to severe traumatic brain injury.Pharmacokinetics of intravenous levofloxacin administered at 750 milligrams in obese adults.Animal modelling of traumatic brain injury in preclinical drug development: where do we go from here?Effect of Traumatic Brain Injury, Erythropoietin, and Anakinra on Hepatic Metabolizing Enzymes and Transporters in an Experimental Rat Model.Moderate hypothermia prevents cardiac arrest-mediated suppression of drug metabolism and induction of interleukin-6 in rats.Cyclosporine A for neuroprotection: establishing dosing guidelines for safe and effective use.A review of psychophysiological stressors on pharmacokinetics.Contemporary pharmacologic issues in the management of traumatic brain injury.Drug absorption, distribution, metabolism and excretion considerations in critically ill adults.Novel therapeutic strategies for traumatic brain injury: acute antioxidant reinforcement.Sex and gender influences on pharmacological response: an overview.Peptide Pharmacological Approaches to Treating Traumatic Brain Injury: a Case for Arginine-Rich Peptides.A prospective pilot study on serum cleaved tau protein as a neurological marker in severe traumatic brain injury.Effects of the nitrone radical scavengers PBN and S-PBN on in vivo trapping of reactive oxygen species after traumatic brain injury in rats.Pharmacokinetic Behavior of Phenytoin in Head Trauma and Cerebrovascular Accident Patients in an Iranian Population.Antiepileptic drugs in critically ill patients.
P2860
Q27027689-85962CED-C9DB-4EC6-B114-E77A1545EA39Q33370507-8631AFA6-3CEC-4A07-9745-32A734DD25BDQ34090573-B4CBE184-4E73-403C-B64C-F6BDF53B5BC0Q34419809-3A85972E-87CF-490C-BC10-BE214EF90263Q35065775-4DD8E57C-E740-4E31-A4A1-29D2B993788AQ35589949-AF74432B-AF69-4963-8AAD-08F6386F7CC9Q35967863-0E7FA07E-AA4D-4A22-B7C6-7ECA46F79963Q37035286-F038AE8A-56F3-4501-976C-1E01ECC98045Q37528454-393BC39F-583D-4F45-BB8A-5B89EEC9D005Q37831732-870411F1-3039-48FC-933A-87C148F8749FQ37867299-8CA93AE7-574B-488A-80E2-44E082CC5C53Q38107537-AE7C6DD5-0459-496C-8B7C-539938A01DCFQ38188467-4A6C2737-BD88-41D2-982D-B378FFC281B2Q38214338-26D2E072-4627-4E02-8CBB-EAFA07B0F6F9Q39008879-3162BBD5-7942-433F-B313-CE99820B29E8Q42043690-0B9E82B1-E460-4351-AB6E-956F78F09F9AQ43794808-848EEE2B-CE32-48C4-BDB9-07C5A0A95568Q49750285-23CF8905-C748-4C7F-B38C-416F26191D58Q55190397-431505C3-D2A2-41E5-A7E3-310AF5D0D2E4
P2860
Pharmacokinetic alterations after severe head injury. Clinical relevance.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Pharmacokinetic alterations after severe head injury. Clinical relevance.
@en
type
label
Pharmacokinetic alterations after severe head injury. Clinical relevance.
@en
prefLabel
Pharmacokinetic alterations after severe head injury. Clinical relevance.
@en
P1476
Pharmacokinetic alterations after severe head injury. Clinical relevance.
@en
P2093
P304
P356
10.2165/00003088-199835030-00004
P577
1998-09-01T00:00:00Z
P6179
1038340947